Literature DB >> 14657785

Advance directives for health care and research: prevalence and correlates.

Gina Bravo1, Marie-France Dubois, Mariane Pâquet.   

Abstract

Patients suffering from Alzheimer disease and other types of dementia gradually lose their decision-making capacity. Advance directives have been widely promoted as a means to maintain some control over one's life in the event of decisional incompetence. This study used data from a recent postal survey conducted in Quebec, Canada to: 1) estimate the prevalence of formal and informal advance directives for health care and research among community-dwelling older adults presumed free of cognitive deficits; and 2) characterize those who have communicated their preferences regarding health care and research participation. Prevalence rates vary from 7.4% (formal advance directives for research) to 42.3% (informal advance directives for health care). Following multivariate logistic regressions, individuals who have communicated their wishes regarding future health care were found to be older, predominantly women, and to more often know someone with cognitive impairment. Those who have expressed their wishes regarding future research involvement were more inclined to participate in research. They were also more likely to have discussed or written advance directives for health care. The finding that only a small proportion of older adults have discussed future research participation with their families points to the need to find effective ways to promote advance directives for research in this population.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach; Health Care and Public Health

Mesh:

Year:  2003        PMID: 14657785     DOI: 10.1097/00002093-200310000-00004

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  23 in total

1.  Do personality traits moderate the impact of care receipt on end-of-life care planning?

Authors:  Jung-Hwa Ha; Manacy Pai
Journal:  Gerontologist       Date:  2012-03-28

Review 2.  Inclusion of patients with severe mental illness in clinical trials: issues and recommendations surrounding informed consent.

Authors:  Sander P K Welie; Ron L P Berghmans
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  The ethics of informed consent in Alzheimer disease research.

Authors:  Scott Y H Kim
Journal:  Nat Rev Neurol       Date:  2011-05-24       Impact factor: 42.937

4.  Transgender and gender non-conforming adult preparedness for aging: Concerns for aging, and familiarity with and engagement in planning behaviors.

Authors:  Richard S Henry; Paul B Perrin; Bethany M Coston; Tarynn M Witten
Journal:  Int J Transgend Health       Date:  2019-11-13

5.  "I don't want to die like that ...": the impact of significant others' death quality on advance care planning.

Authors:  Deborah Carr
Journal:  Gerontologist       Date:  2012-04-30

6.  Ethical issues in diagnosing and treating Alzheimer disease.

Authors:  Edmund G Howe
Journal:  Psychiatry (Edgmont)       Date:  2006-05

7.  Frequency and correlates of advance planning among cognitively impaired older adults.

Authors:  Jennifer Hagerty Lingler; Karen B Hirschman; Linda Garand; Mary Amanda Dew; James T Becker; Richard Schulz; Steven T Dekosky
Journal:  Am J Geriatr Psychiatry       Date:  2008-08       Impact factor: 4.105

8.  Informed consent to research in long-term care settings.

Authors:  Jennifer Hagerty Lingler; Rita A Jablonski; Meg Bourbonniere; Ann Kolanowski
Journal:  Res Gerontol Nurs       Date:  2009-05-29       Impact factor: 1.571

9.  'Til Death Do Us Part: End-of-Life Experiences of Married Couples in a Nationally Representative Survey.

Authors:  Ashwin A Kotwal; Emily Abdoler; L Grisell Diaz-Ramirez; Amy S Kelley; Katherine A Ornstein; W John Boscardin; Alexander K Smith
Journal:  J Am Geriatr Soc       Date:  2018-09-25       Impact factor: 5.562

10.  Stroke genetic research and adults with impaired decision-making capacity: a survey of IRB and investigator practices.

Authors:  Donna T Chen; James F Meschia; Thomas G Brott; Robert D Brown; Bradford B Worrall
Journal:  Stroke       Date:  2008-07-24       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.